Integrated BioTherapeutics

A biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

Launch date

2005

Employees

Market cap

Enterprise valuation

Rockville Maryland (HQ)

Date	Investors	Amount	Round
-	Novo Holdings	N/A	-
Nov 2017	CARB-X	$8.3m	Grant
Mar 2019	N/A	N/A	-
Jul 2019	National Institute for Allergy and Infectious Diseases Bill & Melinda Gates Foundation CARB-X German Federal Ministry of Education and Research (BMBF) Biomedical Advanced Research and Development Authority (BARDA)	$1.6m	Grant
May 2023*	N/A	$1.0m	Seed
Total Funding		AUD16.8m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Integrated BioTherapeutics